AngioDynamics, Inc.
ANGO · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $76 | $80 | $72 | $73 |
| % Growth | -5.5% | 11.3% | -1.2% | – |
| Cost of Goods Sold | $34 | $38 | $33 | $33 |
| Gross Profit | $42 | $42 | $39 | $40 |
| % Margin | 55.3% | 52.7% | 54% | 54.8% |
| R&D Expenses | $6 | $7 | $7 | $6 |
| G&A Expenses | $13 | $10 | $10 | $10 |
| SG&A Expenses | $41 | $37 | $36 | $36 |
| Sales & Mktg Exp. | $28 | $26 | $26 | $26 |
| Other Operating Expenses | $5 | $5 | $6 | $9 |
| Operating Expenses | $53 | $48 | $49 | $51 |
| Operating Income | -$11 | -$6 | -$10 | -$11 |
| % Margin | -14.1% | -7.2% | -13.9% | -15.2% |
| Other Income/Exp. Net | -$0 | -$0 | $6 | $0 |
| Pre-Tax Income | -$11 | -$6 | -$4 | -$11 |
| Tax Expense | $0 | -$0 | -$0 | -$0 |
| Net Income | -$11 | -$6 | -$4 | -$11 |
| % Margin | -14.4% | -7.5% | -6.1% | -14.7% |
| EPS | -0.26 | -0.15 | -0.11 | -0.26 |
| % Growth | -73.3% | -36.4% | 57.7% | – |
| EPS Diluted | -0.26 | -0.15 | -0.11 | -0.26 |
| Weighted Avg Shares Out | 41 | 41 | 41 | 41 |
| Weighted Avg Shares Out Dil | 41 | 41 | 41 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $6 | $6 | $6 | $7 |
| EBITDA | -$5 | $2 | -$0 | $2 |
| % Margin | -6.4% | 2.7% | -0.5% | 2.5% |